(VIANEWS) - Highway Holdings Limited (HIHO), AbbVie (ABBV), Ares Management L.P. (ARES) are the highest payout ratio stocks on this list.
We have gathered information regarding stocks with the highest payout ratio up until now. The payout ratio in itself isn't a promise of good investment but it's an indicator of whether dividends are being paid and how the company chooses to distribute them.
When investigating a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.
1. Highway Holdings Limited (HIHO)
900% Payout Ratio
Highway Holdings Limited, together with its subsidiaries, manufactures and supplies metal, plastic, electric, and electronic components, subassemblies, and finished products for original equipment manufacturers (OEMs) and contract manufacturers.
Volume
Today's last reported volume for Highway Holdings Limited is 3159, 96.56% below its average volume of 91926.
As claimed by Morningstar, Inc., the next dividend payment is on Sep 2, 2021, the estimated forward annual dividend rate is 0.24 and the estimated forward annual dividend yield is 5.91%.
Year-on-year quarterly revenue growth grew by 23.7%, now sitting on 10.75M for the twelve trailing months.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 1.22%.
Volatility
Highway Holdings Limited's last day, week, and month's current volatility was 2.46%, 1.78%, and 2.59%, respectively.
Highway Holdings Limited's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 15.00% (day), 7.00% (last week), and 4.73% (last month), respectively.
Highway Holdings Limited's Stock Yearly Top and Bottom Value
Highway Holdings Limited's stock is valued at $4.25 at 02:23 EST, way below its 52-week high of $5.82 and way above its 52-week low of $2.92.
Highway Holdings Limited's Moving Average
Highway Holdings Limited's value is above its 50-day moving average of $3.90 and way above its 200-day moving average of $3.70.2. AbbVie (ABBV)
134.05% Payout Ratio
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the United States, Japan, Germany, Canada, France, Spain, Italy, the Netherlands, the United Kingdom, Brazil, and internationally.
Volume
Today's last reported volume for AbbVie is 4346880, 38.99% below its average volume of 7125020.
According to Morningstar, Inc., the next dividend payment is on Oct 13, 2021, the estimated forward annual dividend rate is 5.2 and the estimated forward annual dividend yield is 4.78%.
AbbVie's sales growth this year is expected to be 23% and 6% for next year.
Year-on-year quarterly revenue growth grew by 33.9%, now sitting on 53.73B for the twelve trailing months.
AbbVie's sales growth is 11.4% for the present quarter and 8.8% for the next. The company's growth estimates for the current quarter and the next is 14.5% and 13.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 48.86%.
Volatility
AbbVie's last day, week, and month's current volatility was 0.32%, 0.68%, and 0.82%, respectively.
AbbVie's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.68% (day), 1.38% (last week), and 1.58% (last month), respectively.
AbbVie's Stock Yearly Top and Bottom Value
AbbVie's stock is valued at $109.14 at 02:23 EST, way below its 52-week high of $121.53 and way above its 52-week low of $79.11.
AbbVie's Moving Average
AbbVie's value is above its 50-day moving average of $108.49 and under its 200-day moving average of $113.02.Previous days news about AbbVie (ABBV)
- According to Benzinga on Wednesday, 20 October, "In addition to Otezla, there are a few other drugs such as Humira (adalimumab) from AbbVie Inc. (NYSE:ABBV) and Cosentyx (secukinumab) by Novartis International AG (NYSE:NVS) available on the market that help manage symptoms."
- According to Benzinga on Wednesday, 20 October, "Furthermore, the Company has established a strategic collaboration with AbbVie in the area of autoimmune diseases. "
3. Ares Management L.P. (ARES)
95.6% Payout Ratio
Ares Management Corporation operates as an alternative asset manager in the United States, Europe, and Asia.
Volume
Today's last reported volume for Ares Management L.P. is 469135, 28.59% below its average volume of 656962.
As stated by Morningstar, Inc., the next dividend payment is on Sep 14, 2021, the estimated forward annual dividend rate is 1.88 and the estimated forward annual dividend yield is 2.3%.
Ares Management L.P.'s sales growth this year is expected to be 22.1% and 28% for next year.
Year-on-year quarterly revenue growth grew by 114.8%, now sitting on 3.1B for the twelve trailing months.
Ares Management L.P.'s sales growth is 7.9% for the present quarter and negative 2% for the next. The company's growth estimates for the ongoing quarter and the next is 29.2% and 31.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 25.36%.
Volatility
Ares Management L.P.'s last day, week, and month's current volatility was 0.80%, 1.35%, and 1.40%, respectively.
Ares Management L.P.'s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.69% (day), 2.13% (last week), and 2.43% (last month), respectively.
Ares Management L.P.'s Stock Yearly Top and Bottom Value
Ares Management L.P.'s stock is valued at $81.67 at 02:23 EST, under its 52-week high of $81.78 and way above its 52-week low of $40.56.
Ares Management L.P.'s Moving Average
Ares Management L.P.'s value is above its 50-day moving average of $77.36 and way above its 200-day moving average of $65.68.4. Ormat Technologies (ORA)
38.33% Payout Ratio
Ormat Technologies, Inc. engages in the geothermal and recovered energy power business in the United States, Indonesia, Kenya, Turkey, Chile, Guatemala, New Zealand, Honduras, and internationally.
Volume
Today's last reported volume for Ormat Technologies is 428762, 36.86% above its average volume of 313263.
As stated by Morningstar, Inc., the next dividend payment is on Aug 16, 2021, the estimated forward annual dividend rate is 0.48 and the estimated forward annual dividend yield is 0.67%.
Ormat Technologies's sales growth this year is anticipated to be negative 6.4% and 22.3% for next year.
Year-on-year quarterly revenue growth declined by 16%, now sitting on 651.58M for the twelve trailing months.
Ormat Technologies's sales growth is negative 2.6% for the ongoing quarter and 6.8% for the next. The company's growth estimates for the present quarter and the next is negative 9.7% and 46.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.51%.
Volatility
Ormat Technologies's last day, week, and month's current volatility was 1.37%, 2.28%, and 1.80%, respectively.
Ormat Technologies's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.58% (day), 3.49% (last week), and 2.66% (last month), respectively.
Ormat Technologies's Stock Yearly Top and Bottom Value
Ormat Technologies's stock is valued at $73.13 at 02:23 EST, way under its 52-week high of $128.87 and way higher than its 52-week low of $63.71.